CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, D. X.
Right arrow Articles by Kadlubar, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, D. X.
Right arrow Articles by Kadlubar, F. F.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 11 1013-1018, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1

DX Lin, YM Tang, Q Peng, SX Lu, CB Ambrosone and FF Kadlubar
Department of Chemical Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Science and Beijing Union Medical College, People's Republic of China.

Genetic polymorphisms in enzymes involved in carcinogen metabolism have been shown to influence susceptibility to cancer. Cytochrome P450 2E1 (CYP2E1) is primarily responsible for the bioactivation of many low molecular weight carcinogens, including certain nitrosamines, whereas glutathione S-transferases (GSTs) are involved in detoxifying many other carcinogenic electrophiles. Esophageal cancer, which is prevalent in China, is hypothesized to be related to environmental nitrosamine exposure. Thus, we conducted a pilot case-control study to examine the association between CYP2E1, GSTM1, GSTT1, and GSTP1 genetic polymorphisms and esophageal cancer susceptibility. DNA samples were isolated from surgically removed esophageal tissues or scraped esophageal epithelium from cases with cancer (n = 45), cases with severe epithelial hyperplasia (n = 45), and normal controls (n = 46) from a high-risk area, Linxian County, China. RFLPs in the CYP2E1 and the GSTP1 genes were determined by PCR amplification followed by digestion with RsaI or DraI and Alw26I, respectively. Deletion of the GSTM1 and GSTT1 genes was examined by a multiplex PCR. The CYP2E1 polymorphism detected by RsaI was significantly different between controls (56%) and cases with cancer (20%) or severe epithelial hyperplasia (17%; P < 0.001). Persons without the RsaI variant alleles had more than a 4-6-fold risk of developing severe epithelial hyperplasia (adjusted odds ratio, 6.0; 95% confidence interval, 2.3-16.0) and cancer (adjusted odds ratio, 4.8; 95% confidence interval, 1.8-12.4). Polymorphisms in the GSTs were not associated with increased esophageal cancer risk. These results indicate that CYP2E1 may be a genetic susceptibility factor involved in the early events leading to the development of esophageal cancer.


This article has been cited by other articles:


Home page
ANN OCCUP HYGHome page
B. LAFFON, J. P. TEIXEIRA, S. SILVA, J. ROMA-TORRES, B. PEREZ-CADAHIA, J. MENDEZ, E. PASARO, and O. MAYAN
Assessment of Occupational Genotoxic Risk in the Production of Rubber Tyres
Ann. Hyg., August 1, 2006; 50(6): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Cai, L.-N. Mu, H. Lu, Q.-Y. Lu, N.-C. Y. You, S.-Z. Yu, A. D. Le, J. Zhao, X.-F. Zhou, J. Marshall, et al.
Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 294 - 300.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. E. Hur, J. Y. Lee, H.-S. Moon, and H. W. Chung
Polymorphisms of the genes encoding the GSTM1, GSTT1 and GSTP1 in Korean women: no association with endometriosis
Mol. Hum. Reprod., January 1, 2005; 11(1): 15 - 19.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Gao, T. Takezaki, J. Wu, Z. Li, J. Wang, J. Ding, Y. Liu, X. Hu, T. Xu, K. Tajima, et al.
Interaction between Cytochrome P-450 2E1 Polymorphisms and Environmental Factors with Risk of Esophageal and Stomach Cancers in Chinese
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 29 - 34.
[Abstract] [Full Text]


Home page
BloodHome page
K. A. Lee, S. H. Kim, H. Y. Woo, Y. J. Hong, and H. C. Cho
Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia
Blood, December 1, 2001; 98(12): 3483 - 3485.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Sweeney, G. Y. McClure, M. Y. Fares, A. Stone, B. F. Coles, P. A. Thompson, S. Korourian, L. F. Hutchins, F. F. Kadlubar, and C. B. Ambrosone
Association between Survival after Treatment for Breast Cancer and Glutathione S-Transferase P1 Ile105Val Polymorphism
Cancer Res., October 1, 2000; 60(20): 5621 - 5624.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. N. Nishimoto, T. Hanaoka, H. Sugimura, K. Nagura, M. Ihara, X.-J. Li, T. Arai, G. S. Hamada, L. P. Kowalski, and S. Tsugane
Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians
Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 675 - 680.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Tan, N. Song, G.-Q. Wang, Q. Liu, H.-J. Tang, F. F. Kadlubar, and D.-X. Lin
Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione S-Transferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 551 - 556.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. M. Whyatt, F. P. Perera, W. Jedrychowski, R. M. Santella, S. Garte, and D. A. Bell
Association between Polycyclic Aromatic Hydrocarbon-DNA Adduct Levels in Maternal and Newborn White Blood Cells and Glutathione S-Transferase P1 and CYP1A1 Polymorphisms
Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 207 - 212.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. L. Marchand, G. R. Wilkinson, and L. R. Wilkens
Genetic and Dietary Predictors of CYP2E1 Activity: A Phenotyping Study in Hawaii Japanese Using Chlorzoxazone
Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 495 - 500.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.